Clinical trials
Waldenstrom Macroglobulinemia trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
| Completed | 6 |
| Active, not recruiting | 5 |
| Terminated | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeOne Medicines | 2 |
| Gilead Sciences | 2 |
| Janssen Research & Development, LLC | 2 |
| AbbVie | 1 |
| Acerta Pharma BV | 1 |
| BeiGene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Eli Lilly and Company | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Waldenstrom Macroglobulinemia | 23 |
| Lymphoma, B-Cell, Marginal Zone | 13 |
| Lymphoma, Follicular | 13 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 12 |
| Lymphoma, Mantle-Cell | 12 |
| Lymphoma, Large B-Cell, Diffuse | 8 |
| Lymphoma, Non-Hodgkin | 8 |
| Lymphoma | 5 |
| Recurrence | 5 |
| Burkitt Lymphoma | 3 |
Trials
Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.